• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-520f通过调控成纤维细胞生长因子16促进肝癌细胞的侵袭性。

MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma.

作者信息

Xu Feng Feng, Xie Wen Feng, Zha Guo Qing, Chen Hong Wu, Deng Liang

机构信息

Department II of General Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China.

Department of Intensive Care Unit, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510700, China.

出版信息

Oncotarget. 2017 Nov 30;8(65):109546-109558. doi: 10.18632/oncotarget.22726. eCollection 2017 Dec 12.

DOI:10.18632/oncotarget.22726
PMID:29312628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752541/
Abstract

Cancer metastasis is a multistep cellular process, which has be confirmed one of mainly causes of cancer associated-death in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) participate in tumorigenesis function as either tumor suppressor genes or oncogenes. In order to elaborate the critical miRNAs and their targets in HCC, we compared the differential expression of miRNA between HCC tissues and normal tissues. Microarray analysis revealed there were several significantly up-expression miRNAs in HCC, compared to normal solid tissue. Among them, the expression of miR-520f was the most over-expression in HCC cell lines than that in human normal liver cells LO2, as well as up-regulated in HCC than that in the corresponding normal tissues. Moreover, Kaplan Meier-plotter analyses revealed that higher miR-520f levels were negatively correlated with poor overall survival. By applying bioinformatics methods to identify the targeting genes of miRNA, we demonstrated that fibroblast growth factor 16 (FGF16) was the miR-520f-targeted gene. Meanwhile, FGF16 exhibited similar expression patterns to miR-520f in HCC. Forced miR-520f expression accelerated HCC cells proliferation and aggressiveness and , whereas down-regulation of miR-520f caused an opposite outcome. Moreover, over-expression of FGF16 was closely related to the metastatic potential of HCC cells. Herein, we also confirmed that ectopic expression of FGF16 in HCC cells promoted proliferation, colony formation, and increased migration, invasion of HCC cells . Collectively, our results indicated that over-expression of miR-520f and FGF16 was positively associated with aggressive phenotypes and poor survival of patients with HCC, and miR-520f promoted HCC aggressive phenotypes by regulating the expression of FGF16. MiR-520f may be employed as a prognostic factor and therapeutic target for HCC.

摘要

癌症转移是一个多步骤的细胞过程,已被确认为肝细胞癌(HCC)中与癌症相关死亡的主要原因之一。微小RNA(miRNA)作为肿瘤抑制基因或癌基因参与肿瘤发生功能。为了阐明HCC中关键的miRNA及其靶标,我们比较了HCC组织与正常组织中miRNA的差异表达。微阵列分析显示,与正常实体组织相比,HCC中有几种miRNA显著上调。其中,miR-520f在HCC细胞系中的表达比在人正常肝细胞LO2中过度表达最多,并且在HCC中比在相应的正常组织中上调。此外,Kaplan Meier绘图分析显示,较高的miR-520f水平与总体生存率差呈负相关。通过应用生物信息学方法鉴定miRNA的靶向基因,我们证明成纤维细胞生长因子16(FGF16)是miR-520f靶向的基因。同时,FGF16在HCC中的表达模式与miR-520f相似。强制表达miR-520f可加速HCC细胞增殖和侵袭,而miR-520f的下调则产生相反的结果。此外,FGF16的过表达与HCC细胞的转移潜能密切相关。在此,我们还证实HCC细胞中FGF16的异位表达促进了增殖、集落形成,并增加了HCC细胞的迁移和侵袭。总体而言,我们的结果表明,miR-520f和FGF16的过表达与HCC患者的侵袭性表型和不良生存呈正相关,并且miR-520f通过调节FGF16的表达促进HCC侵袭性表型。MiR-520f可作为HCC的预后因素和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/86ce20ee92cc/oncotarget-08-109546-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/3b6e192c1a35/oncotarget-08-109546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/f8c9030769be/oncotarget-08-109546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/d2c95c3651c5/oncotarget-08-109546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/51aab54dec2e/oncotarget-08-109546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/610755acb644/oncotarget-08-109546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/dafda33a677c/oncotarget-08-109546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/86ce20ee92cc/oncotarget-08-109546-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/3b6e192c1a35/oncotarget-08-109546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/f8c9030769be/oncotarget-08-109546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/d2c95c3651c5/oncotarget-08-109546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/51aab54dec2e/oncotarget-08-109546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/610755acb644/oncotarget-08-109546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/dafda33a677c/oncotarget-08-109546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/742e/5752541/86ce20ee92cc/oncotarget-08-109546-g007.jpg

相似文献

1
MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma.微小RNA-520f通过调控成纤维细胞生长因子16促进肝癌细胞的侵袭性。
Oncotarget. 2017 Nov 30;8(65):109546-109558. doi: 10.18632/oncotarget.22726. eCollection 2017 Dec 12.
2
microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.微小RNA-520f通过靶向TM4SF1抑制肝癌细胞的增殖和侵袭。
Gene. 2018 May 30;657:30-38. doi: 10.1016/j.gene.2018.03.003. Epub 2018 Mar 2.
3
MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).MicroRNA-520f 通过靶向 ATP 酶家族 AAA 结构域包含蛋白 2(ATAD2)抑制胃癌细胞的生长。
Neoplasma. 2016;63(6):873-879. doi: 10.4149/neo_2016_606.
4
MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling.miR-520f-3p 通过靶向 SOX9 抑制胃癌细胞增殖,从而使 Wnt 信号失活。
Sci Rep. 2020 Apr 10;10(1):6197. doi: 10.1038/s41598-020-63279-y.
5
Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.雄激素受体 (AR)/miR-520f-3p/ Sox9 信号通路通过增加肿瘤干细胞表型,参与改变低氧环境下肝细胞癌 (HCC) 细胞对索拉非尼治疗的敏感性。
Cancer Lett. 2019 Mar 1;444:175-187. doi: 10.1016/j.canlet.2018.11.004. Epub 2018 Nov 15.
6
MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.微小RNA-451a通过靶向14-3-3ζ抑制肝癌细胞的增殖、转移和上皮-间质转化。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5158-5167. doi: 10.26355/eurrev_201906_18180.
7
Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.miR-211-5p 通过靶向 ACSL4 抑制肝癌发生发展
J Transl Med. 2020 Aug 28;18(1):326. doi: 10.1186/s12967-020-02494-7.
8
MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.microRNA-769-5p 通过衰减 RYBP 促进肝癌细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2019 Oct;118:109343. doi: 10.1016/j.biopha.2019.109343. Epub 2019 Aug 13.
9
EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.EZH2-H3K27me3 介导的 miR-139-5p 沉默通过激活 TOP2A 抑制肝癌细胞衰老。
J Exp Clin Cancer Res. 2023 Nov 27;42(1):320. doi: 10.1186/s13046-023-02855-2.
10
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.microRNA-188-5p 通过直接靶向肝细胞癌中的 FGF5 抑制肿瘤细胞增殖和转移。
J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.

引用本文的文献

1
Fibroblast growth factor 16: Molecular mechanisms, signalling crosstalk, and emerging roles in cardiac biology and metabolic regulation.成纤维细胞生长因子16:分子机制、信号串扰以及在心脏生物学和代谢调节中的新作用
Pharmacol Res. 2025 Aug;218:107858. doi: 10.1016/j.phrs.2025.107858. Epub 2025 Jul 13.
2
Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications.成纤维细胞生长因子:作用及新兴治疗应用
Curr Drug Targets. 2025;26(8):551-570. doi: 10.2174/0113894501351461250301072444.
3
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance.

本文引用的文献

1
A New Network-Based Strategy for Predicting the Potential miRNA-mRNA Interactions in Tumorigenesis.一种基于网络的预测肿瘤发生中潜在miRNA-mRNA相互作用的新策略。
Int J Genomics. 2017;2017:3538568. doi: 10.1155/2017/3538568. Epub 2017 Aug 2.
2
Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study.原发性肝癌远处肝外转移模式:一项基于监测、流行病学和最终结果(SEER)数据库的研究
J Cancer. 2017 Jul 21;8(12):2312-2318. doi: 10.7150/jca.19056. eCollection 2017.
3
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
解码成纤维细胞生长因子/成纤维细胞生长因子受体信号传导:对生物学功能和疾病相关性的见解
Biomolecules. 2024 Dec 18;14(12):1622. doi: 10.3390/biom14121622.
4
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer.全面的基于计算机的分析预测因子和免疫浸润物在人类卵巢癌中的 FGFs 作用。
J Ovarian Res. 2024 Oct 9;17(1):197. doi: 10.1186/s13048-024-01496-z.
5
Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells.通过 PFKFB4 对葡萄糖代谢的重编程在 FGF16 驱动的乳腺癌细胞侵袭中至关重要。
Biosci Rep. 2023 Aug 31;43(8). doi: 10.1042/BSR20230677.
6
MicroRNA-7 inhibits hepatocellular carcinoma cell invasion and metastasis by regulating Atg5-mediated autophagy.微小RNA-7通过调节自噬相关基因5(Atg5)介导的自噬抑制肝癌细胞的侵袭和转移。
Transl Cancer Res. 2020 Jun;9(6):3965-3972. doi: 10.21037/tcr-20-1930.
7
FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer.受miR-520b调控的FGF16增强肺癌细胞增殖。
Open Med (Wars). 2021 Mar 15;16(1):419-427. doi: 10.1515/med-2021-0232. eCollection 2021.
8
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.微小RNA-3690通过改变人甲状腺癌中DKK3的表达促进细胞增殖和细胞周期进程。
Oncol Lett. 2020 Nov;20(5):223. doi: 10.3892/ol.2020.12086. Epub 2020 Sep 10.
9
Overexpressing lncRNA inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93.长链非编码RNA过表达通过功能性结合hsa-miR-93抑制肝癌细胞增殖和化疗耐药性。
Onco Targets Ther. 2018 Dec 7;11:8855-8863. doi: 10.2147/OTT.S182005. eCollection 2018.
10
Prospects of Noncoding RNAs in Hepatocellular Carcinoma.非编码 RNA 在肝细胞癌中的研究前景。
Biomed Res Int. 2018 Jul 26;2018:6579436. doi: 10.1155/2018/6579436. eCollection 2018.
成纤维细胞生长因子(FGFs)在癌症中的作用:FGF 陷阱作为一种新的治疗方法。
Pharmacol Ther. 2017 Nov;179:171-187. doi: 10.1016/j.pharmthera.2017.05.013. Epub 2017 May 28.
4
POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.POU2F1的过表达与不良预后相关,并促进肝癌细胞的生长和上皮-间质转化。
Oncotarget. 2017 Jul 4;8(27):44082-44095. doi: 10.18632/oncotarget.17296.
5
High-yield of biologically active recombinant human fibroblast growth factor-16 in E. coli and its mechanism of proliferation in NCL-H460 cells.大肠杆菌中生物活性重组人成纤维细胞生长因子-16的高产表达及其在NCL-H460细胞中的增殖机制
Prep Biochem Biotechnol. 2017 Aug 9;47(7):720-729. doi: 10.1080/10826068.2017.1315599. Epub 2017 Apr 14.
6
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.FAT1 通过 MAPK/ERK 信号通路防止食管鳞癌细胞发生上皮间质转化(EMT)。
Cancer Lett. 2017 Jul 1;397:83-93. doi: 10.1016/j.canlet.2017.03.033. Epub 2017 Mar 31.
7
miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting and .miRNA-520f 通过靶向 和 逆转上皮间质转化。
Cancer Res. 2017 Apr 15;77(8):2008-2017. doi: 10.1158/0008-5472.CAN-16-2609. Epub 2017 Feb 16.
8
MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).MicroRNA-520f 通过靶向 ATP 酶家族 AAA 结构域包含蛋白 2(ATAD2)抑制胃癌细胞的生长。
Neoplasma. 2016;63(6):873-879. doi: 10.4149/neo_2016_606.
9
MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1.miR-139-3p 通过靶向 NOB1 诱导宫颈癌细胞凋亡并抑制转移。
Biomed Pharmacother. 2016 Oct;83:850-856. doi: 10.1016/j.biopha.2016.07.050. Epub 2016 Aug 6.
10
RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.RNF8促进乳腺癌细胞的上皮-间质转化。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):88. doi: 10.1186/s13046-016-0363-6.